HEMOSTATIC SIDEARM— 510(k) K854397

Substantially Equivalent

Target Therapeutics

FDA 510(k) clearance K854397 for HEMOSTATIC SIDEARM, Substantially Equivalent on 1986-01-08. Applicant: Target Therapeutics.

Clearance details

Applicant: Target Therapeutics
Product code: Code DTL
Advisory panel: Cardiovascular
Date received: 1985-10-31
Decision date: 1986-01-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Los Angeles, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DTL

product code DTL

Malfunction: 770
Total: 770

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.